SARS ‐CoV‐2, bacterial co‐infections, and AMR : the deadly trio in COVID ‐19?
Author(s) -
Bengoechea Jose A,
Bamford Connor GG
Publication year - 2020
Publication title -
embo molecular medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.923
H-Index - 107
eISSN - 1757-4684
pISSN - 1757-4676
DOI - 10.15252/emmm.202012560
Subject(s) - covid-19 , microbiology and biotechnology , virology , biology , medicine , outbreak , infectious disease (medical specialty) , disease , pathology
Respiratory viral infections are well known to predispose patients to bacterial co‐infections and superinfections. Still, there is limited reference to these in COVID ‐19. Do co‐infections play a significant role during COVID ‐19? What is the impact of antimicrobial resistance?
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom